China Sky One’s Cancer Drug Granted “Breakthrough” Status

China Sky One Medical (中国天字一号医药公司) announced its development-stage innovative cancer drug, Antroquinonol (Hocena) capsules, has been recognized as a Breakthrough Drug by China’s Ministry of Science and Technology (MoST). The designation qualifies Antroquinonol for accelerated approvals as well as financial and technical support of its development. More details... Stock Symbol: (NSDQ: CSKI)